Build my plan日本語
← All supplements

Supplement evidence

170 / 575Research index — evidence review pending

Aniracetam

View my plan →

The short answer

No use has passed JIVANA's study-level evidence review yet.

Evidence and scope
Research gathered — evidence review pending

This status does not grade the ingredient for every goal, outcome, or person.

Important limitation
No efficacy conclusion has passed JIVANA's study-level review yet. The linked research index is for discovery, not a benefit claim.
Before deciding
Identity, dose, interactions, product quality, and regulatory status still require review. Do not use this provisional page to decide whether to take it.

02 / EVIDENCE

What the research says

We keep supportive, mixed, negative, safety, and contextual findings together. The headline never replaces the underlying papers.

Study-level extraction is not complete yet.

This research-index page is live so the topic, source trail, and evidence boundaries are visible. Individual studies have not yet passed the JIVANA extraction and review process, so we do not manufacture an efficacy conclusion or research count from broad search results.

Unscreened discovery appendix—not evidence12 candidate publicationsSearch run: Aug 21, 2026

Complete for the displayed PubMed query at the search timestamp—not for all databases or every possible synonym. Candidates can be irrelevant, duplicate the same study, or report negative findings. They are never summed as evidence or participants until screened.

03 / SOURCES

Start with the source material

Official evidence overviewPubMed bounded human-evidence searchLive PubMed discovery searchNational Library of Medicine

The live search is for discovery only. Search-result counts change and are not included in the audited totals above.

Recent PubMed discovery recordsDirect links to the first 12 records returned by the reproducible search. These are discovery candidates—not reviewed summaries or a count of supportive findings.
  1. The treatment of cognitive dysfunction in dementia: a multiple treatments meta-analysis.Perng CH, Chang YC, Tzang RF · 2018 · Psychopharmacology · PMID 29502274Open on PubMed
  2. [Effects of scalp acupuncture combined with auricular point sticking on cognitive behavior ability in patients with vascular dementia].Li SK, Ding DM, Zhang ZL et al. · 2014 · Zhongguo zhen jiu = Chinese acupuncture & moxibustion · PMID 25022106Open on PubMed
  3. [Effect of modified huanglian wendan decoction in treating senile patients with mild cognitive impairment of turbid-phlegm blocking orifice syndrome].Guo RZ, Zhou WQ, Luo ZG · 2010 · Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine · PMID 20353029Open on PubMed
  4. Pharmacokinetics and bioequivalence study of aniracetam after single-dose administration in healthy Chinese male volunteers.Tian Y, Zhang JJ, Feng SD et al. · 2008 · Arzneimittel-Forschung · PMID 19025058Open on PubMed
  5. [A randomized, controlled, double-blind trial of Huannao Yicong capsule in senile patients with mild cognitive impairment].Li H, Yao MJ, Zhao WM et al. · 2008 · Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine · PMID 18184542Open on PubMed
  6. [Clinical study on a randomized, double-blind control of Shenwu gelatin capsule in treatment of mild cognitive impairment].Zhong J, Tian JZ, Zhu AH et al. · 2007 · Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica · PMID 17993008Open on PubMed
  7. Pharmacokinetic study of aniracetam in elderly patients with cerebrovascular disease.Endo H, Tajima T, Yamada H et al. · 1997 · Behavioural brain research · PMID 9062694Open on PubMed
  8. Aniracetam (Ro 13-5057) in the treatment of senile dementia of Alzheimer type (SDAT): results of a placebo controlled multicentre clinical study.Senin U, Abate G, Fieschi C et al. · 1991 · European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · PMID 1822317Open on PubMed
  9. [Efficacy and tolerance of aniracetam in elderly patients with primary or secondary mental deterioration].Canonico V, Forgione L, Paoletti C et al. · 1991 · Rivista di neurologia · PMID 1767242Open on PubMed
  10. Aniracetam tested in chronic psychosyndrome after long-term exposure to organic solvents. A randomized, double-blind, placebo-controlled cross-over study with neuropsychological tests.Somnier FE, Ostergaard MS, Boysen G et al. · 1990 · Psychopharmacology · PMID 2188276Open on PubMed
  11. Senile dementia of the Alzheimer type treated with aniracetam: a new nootropic agent.Sourander LB, Portin R, Mölsä P et al. · 1987 · Psychopharmacology · PMID 3103163Open on PubMed
  12. The hypoxia model in human psychopharmacology: neurophysiological and psychometric studies with aniracetam i.v.Saletu B, Grünberger J · 1984 · Human neurobiology · PMID 6434496Open on PubMed

04 / EXPERT CONTEXT

Expert context—not evidence

Expert positions are dated context—not scientific evidence. They never raise the evidence status or become consensus by repetition.

No direct, source-verified endorsement is currently recorded. Research authorship or discussion alone is not treated as endorsement.

Educational information only—not medical advice. Product quality, dose, medicines, pregnancy, and kidney or liver disease can materially change safety.

Optional analytics

Off by default. Change anytime in Privacy settings.

See what is collected